DERIVATIVE LIABILITIES FOR AUTHORIZED SHARE DEFICIENCIES - Deficiency Triggered by Charter Revision (Details) - USD ($) $ / shares in Units, $ in Thousands |
4 Months Ended | 12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2021 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 16, 2022 |
Jun. 15, 2022 |
May 26, 2022 |
May 01, 2022 |
Jun. 18, 2021 |
Jun. 17, 2021 |
May 26, 2021 |
May 25, 2021 |
Feb. 17, 2021 |
Feb. 16, 2021 |
Aug. 31, 2019 |
|
| DERIVATIVE LIABILITIES FOR AUTHORIZED SHARE DEFICIENCIES | ||||||||||||||
| Common stock, shares authorized | 40,000,000 | 100,000,000 | 100,000,000.0 | 40,000,000.0 | 40,000,000.0 | 40,000,000.0 | 10,000,000.0 | 40,000,000.0 | 10,000,000.0 | 10,000,000.0 | 500,000,000.0 | |||
| Common stock, shares issued | 8,352,000 | 33,582,000 | 8,400,000 | 1 | ||||||||||
| Common stock, shares outstanding | 8,352,000 | 33,582,000 | 8,400,000 | 1 | ||||||||||
| Shares reserved for issuance | 2,400,000 | |||||||||||||
| Common Stock, Required Shares Authorized | 10,800,000 | |||||||||||||
| Common Stock, Deficiency Of Required Shares Authorized | 733,000 | 780,000 | ||||||||||||
| Shares subject to the deficiency, required to settle in cash | 800,000 | |||||||||||||
| Common Stock, Fair Value, Deficiency | $ 1,800 | $ 1,796 | $ 3,591 | |||||||||||
| Expiration of stock options and warrants | 100,000 | |||||||||||||
| Non-cash gain from change in fair value of derivative liabilities | $ 1,800 | |||||||||||||
| Price per share | $ 7.69 | $ 11.99 |
| X | ||||||||||
- Definition The number of common shares below the required amount to be authorized causing a deficiency. No definition available.
|
| X | ||||||||||
- Definition Fair value of the deficient common shares below the required amount to be authorized. No definition available.
|
| X | ||||||||||
- Definition The minimum number of common shares required to be authorized. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of derivative liability. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of stock options and warrants expired. No definition available.
|
| X | ||||||||||
- Definition Represents the number of shares subject to the deficiency, required to settle in cash. No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|